🔎 Trials Near Me

Dachaigh › Scleroderma › Arizona

Sgrùdaidhean clionaigeach Scleroderma ann an Arizona

Tha 6 sgrùdaidhean airson Scleroderma a’ lorg phàirtichean aig làraichean ann an Arizona.

Bailtean ann an Arizona

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  • Banner - University Medicine Rheumatology Clinic, Phoenix
  • Arizona Arthritis and Rheumatology Associates - Paradise Valley, Scottsdale
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07497087

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

  • Arizona Arthritis and Rheumatology Associates, Phoenix
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06655155

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Mayo Clinic, Phoenix
A’ fastadhÌre 1
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Tucson
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05878717

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Phoenix, Phoenix
  • Artiva Investigational Site Tucson, Tucson
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06991114

A Study of AZD0120 in Autoimmune Diseases

  • Research Site, Tucson
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07295847

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.